Concepedia
Statistics
Publications
6
Citations
394
H-Index
Active since
2014
Affiliations
University of Michigan(Current)
University of Pittsburgh
Henry Ford Hospital
University of Pennsylvania
Michigan Medicine
Avery Polk is an author at University of Michigan specializing in medicine, oncology, and cancer immunotherapy.
Publications per year
2014–2019
GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features
Tianjiao Wang, Andrew L. Feldman, David A. Wada et al. · Blood · 2014 · 180 citations · Full text
Medicine, Molecular Biology, Pathology +6
Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability
Carlos Murga‐Zamalloa, Delphine Rolland, Avery Polk et al. · Clinical Cancer Research · 2019 · 67 citations · Full text
Life Sciences, Immunology, Oncology +16
T-cell Receptor Signaling Activates an ITK/NF-κB/GATA-3 axis in T-cell Lymphomas Facilitating Resistance to Chemotherapy
Tianjiao Wang, Ye Lu, Avery Polk et al. · Clinical Cancer Research · 2016 · 56 citations · Full text
Life Sciences, Immunology, Oncology +15
Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia
Avery Polk, Ye Lu, Tianjiao Wang et al. · Clinical Cancer Research · 2016 · 44 citations · Full text
Medicine, Immunology, Pharmacology +13
A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T‐cell lymphomas
Philip S. Boonstra, Avery Polk, Noah A. Brown et al. · American Journal of Hematology · 2017 · 28 citations · Full text
Medicine, Oncology, Pharmacology +16
1–5 of 6